Harrison Clinical Research Selects BioClinica OnPoint CTMS

– Leading European CRO Chooses 'Flexible and Affordable' Clinical Trial Management (CTMS) Technology –

January 17, 2012.  NEWTOWN, PA – BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management solutions, announced today a new agreement with Harrison Clinical Research (HCR), an international full-service contract research organization. After notification that support for its previous CTMS solution would be discontinued, Harrison selected BioClinica OnPoint CTMS to replace that system. HCR decided that OnPoint is the best-in-class solution to provide services to its world-wide client base. Harrison currently supports approximately 80 clinical trials for its clients annually.

"After an extensive product search, we were impressed with BioClinica's technology and the operational efficiencies that it affords," said Monika Huber, Group Compliance Manager and Project Director of Harrison Clinical Research. "A robust CTMS system is critical for us to support trial management and optimal communication with our clients. Both our IT and clinical teams liked BioClinica's team and the technology, and in particular, how flexible and affordable it was compared to other solutions. BioClinica's product roadmap for OnPoint convinced us that it is the right partner for the long haul."

Harrison's in-depth selection process included a pilot project that offered users hands-on validation of OnPoint's capabilities and ease-of-use. "Harrison was already a Microsoft® SharePoint® customer," said Ms. Huber, "and when we saw the offline capabilities – through OnPoint to Outlook and Microsoft Office – we were even more impressed." BioClinica OnPoint leverages native connectivity through SharePoint to extend workflow management to Microsoft Office applications which allow end users to do much of their work using their familiar desktop applications.

"BioClinica is delighted to be chosen by Harrison Clinical Research for its world-wide clinical trial management needs after such a thorough selection process," said Peter Benton, President of eClinical Solutions for BioClinica. "Since launching the latest release of the product eight months ago, we have seen tremendous interest in OnPoint's ability to support global research combined with the flexibility sponsors need to create more efficient eClinical environments."

BioClinica OnPoint CTMS capabilities include: clinical site, personnel, patient and clinical supplies administration; scheduling, tracking and performance monitoring; site payments, study document management; and more. OnPoint CTMS is supported by Microsoft SharePoint and BioClinica technologies to provide superior team collaboration, connectivity and efficiency for multi-site implementations.

About the Harrison Clinical Research Group
Harrison Clinical Research (HCR) is an international contract research organization offering full service clinical research capabilities to the pharmaceutical industry. With Phase I (clinical pharmacology unit in Munich, Germany) to Phase IV capabilities, HCR focuses on providing the services our clients require for the successful clinical development and registration of new pharmaceutical, biological and nutraceuticals products as well as medical devices by delivering the highest quality data, achieving promised enrollment and meeting project timelines.

About BioClinica, Inc.
BioClinica accelerates the development of new medical therapies by delivering expertise and technologies that enhance clinical research, worldwide. Our industry-leading medical imaging services, cardiac safety, and enterprise eClinical platform bring a new level of quality and efficiency to every phase of clinical development. Our experience spans three decades and includes thousands of studies in all therapeutic areas, from design and management, through submission and post-approval. BioClinica serves more than 400 pharmaceutical, biotechnology, and device companies – including all the top 20 - through a network of offices in the U.S., Europe, and Asia.